The patent EP3143995B2 was granted on Jan 15, 2025 by Novartis The patent is currently Patent Maintained As Amended.
Patent Grant Date: Jan 15, 2025
Opposition Deadline: Oct 15, 2025
days remaining to file oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.
Get a free, in-depth citation report including examiner, opposition, and international search citations.
Get Free Citation ReportThe dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents